BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

  March 31, 2025

   · 

  20 min read
• Press Releases

  Phio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update

  Continues advancing clinical trial for INSTASYL siRNA lead product candidate PH-762 3rd Cohort now fully enrolled in on-going clinical study

  March 31, 2025

   · 

  11 min read
• Press Releases

  BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

  Fourth Quarter Revenues Grew 62% to $7.3 Million, Exceeding Prior Management Guidance, with Full Year Revenues Increasing 99% Year-Over-Year to $25.2 Million CDMO Division Secures Anchor Partnership with Tate & Lyle to Develop Next Generation of Plant-Based Sweeteners

  March 31, 2025

   · 

  14 min read
• Press Releases

  Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results

  March 31, 2025

   · 

  20 min read
• Press Releases

  Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the National Kidney Foundation Spring Clinical Meetings 2025

  March 31, 2025

   · 

  15 min read
• Press Releases

  Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update

  March 31, 2025

   · 

  22 min read
• Press Releases

  Cytokinetics to Participate in the 24th Annual Needham Virtual Healthcare Conference

  March 31, 2025

   · 

  3 min read
• Press Releases

  Late-Breaking Clinical Trial Presented at the American College of Cardiology Supports Low-Dose Colchicine, 0.5 mg to Treat Cardiovascular Disease by Reducing Progression of Coronary Plaque

  March 31, 2025

   · 

  6 min read
• Press Releases

  Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference

  March 31, 2025

   · 

  1 min read
• Press Releases

  Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia

  March 31, 2025

   · 

  5 min read